BioCentury | Feb 2, 2015
Clinical News
SynchroMed II regulatory update
...Medtronic submitted a PMA to FDA for its SynchroMed II implantable drug infusion system for use with...
...Tyvaso . United Therapeutics Corp. (NASDAQ:UTHR), Silver Spring, Md. Medtronic plc (NYSE:MDT), Minneapolis, Minn. Product: SynchroMed II...
...Tyvaso . United Therapeutics Corp. (NASDAQ:UTHR), Silver Spring, Md. Medtronic plc (NYSE:MDT), Minneapolis, Minn. Product: SynchroMed II...